EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Role of Metacognition, Intolerance of Uncertainty, and Cognitive‐Attentional Syndrome in Differentiating Fear of Cancer Recurrence

Wendy W T Lam, Danielle W L Ng iD, Ceci Guo, Rachel Ng, Richard Fielding, Chi Chung Foo, Ava Kwong, Siu-Man Simon Ng iD, Dacita Suen, Sara Fung iD, Oi Kwan Chun, Karen K L Chan und 2 weitere

Psycho-Oncology · 2026-05 · 35 (5)

DOI: 10.1002/pon.70475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psycho-Oncology, online erschienen am 29.04.2026. Verfasst von Wendy W T Lam und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Behavioural Sciences, Centre for Psycho-Oncological Research and Training, School of Public Health, The University of Hong Kong, Hong Kon…. Hauptthemen laut MEDLINE: Metacognition, Fear, Neoplasm Recurrence, Local, Cognition. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: General Research Fund of the Research Grants Council of Hong Kong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study tested (1) whether intolerance of uncertainty (IU) and negative metacognitive beliefs independently differentiate fear of cancer recurrence (FCR) status, and (2) whether mediation by cognitive‐attentional syndrome (CAS) elements modify the relationships of IU and metacognitive beliefs with FCR status.

Methods

Baseline data from 384 participants (collected ∼15.6 months post‐diagnosis) pooled from a prospective longitudinal study and an FCR intervention trial were analyzed. Measures included FCRI‐SF (FCR), MCQ‐30 (metacognitive beliefs), IUS‐12 (IU), and CAS‐1 (CAS). FCR status was classified based on the FCRI‐SF scores as non‐clinical (< 13), subclinical (13–21), and clinically significant (≥ 22). Fully adjusted multinomial logistic regression examined direct effects of IU and metacognitive domains on FCR status and indirect effects via CAS.

Results

Compared to the non‐clinical group ( n = 116), subclinical ( n = 190) and clinically‐significant ( n = 78) FCR groups showed greater negative beliefs about worry (OR range 1.297–1.500, p < 0.001), higher IU (OR 1.050–1.066, p = 0.037), increased use of CAS metacognitive strategies (OR 1.077–1.108, p = 0.021‐< 0.001), and less perceived need to control thoughts (OR 0.847–0.857, p = 0.003–0.027). Clinically‐significant FCR was additionally associated with poorer cognitive confidence (OR 1.122, p = 0.030). CAS partially mediated associations of FCR status with negative beliefs about worry, cognitive confidence, and IU, and fully mediated the association with need to control thoughts.

Conclusions

IU and negative metacognitive beliefs can characterize individuals vulnerable to differentially‐elevated FCR. CAS centrally mediates the relationships between FCR, IU, and metacognition. Cognitive‐behavioral interventions for FCR explicitly targeting CAS should disrupt the impact of IU and metacognitive beliefs on FCR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetacognitionFearNeoplasm Recurrence, LocalCognitionAttentionNeoplasmsHumansFemaleUncertaintyMaleMiddle AgedProspective StudiesLongitudinal StudiesAdultAged

Stichwörter der Autor:innen

cancer survivorshipcognitive‐attentional syndromefear of cancer recurrenceintolerance of uncertaintymetacognition

Autor:innen und Institutionen

  • Division of Behavioural Sciences, Centre for Psycho-Oncological Research and Training, School of Public Health, The University of Hong Kong, Hong Kong, Hong Kong.
  • LKS Faculty of Medicine, HKU Jockey Club Institute of Cancer Care, The University of Hong Kong, Hong Kong, Hong Kong.
  • Department of Surgery, The University of Hong Kong, Hong Kong, Hong Kong.
  • Department of Surgery, The Chinese University of Hong Kong, Hong Kong, Hong Kong.
  • Department of Surgery, Kwong Wah Hospital, Hong Kong Hospital Authority, Hong Kong, Hong Kong.
  • Department of Obstetric and Gynaecology, The University of Hong Kong, Hong Kong, Hong Kong.

ORCID-Profile: Danielle W L Ng, Siu-Man Simon Ng, Sara Fung

Förderung

  • General Research Fund of the Research Grants Council of Hong Kong

Zitieren

APA

Lam, W. W. T., Ng, D. W. L., Guo, C., Ng, R., Fielding, R., Foo, C. C., Kwong, A., Simon Ng, S. M., Suen, D., Fung, S., Chun, O. K., Chan, K. K. L., Chan, W. W. L., & Chang, A. T. Y. (2026). The Role of Metacognition, Intolerance of Uncertainty, and Cognitive‐Attentional Syndrome in Differentiating Fear of Cancer Recurrence. Psycho-Oncology, 35(5). https://doi.org/10.1002/pon.70475

Vancouver

Lam WWT, Ng DWL, Guo C, Ng R, Fielding R, Foo CC, et al. The Role of Metacognition, Intolerance of Uncertainty, and Cognitive‐Attentional Syndrome in Differentiating Fear of Cancer Recurrence. Psycho-Oncology. 2026;35(5). doi:10.1002/pon.70475

BibTeX
@article{Lam2026,
  author = {Lam, Wendy W T and Ng, Danielle W L and Guo, Ceci and Ng, Rachel and Fielding, Richard and Foo, Chi Chung and Kwong, Ava and Simon Ng, Siu-Man and Suen, Dacita and Fung, Sara and Chun, Oi Kwan and Chan, Karen K L and Chan, Wendy W L and Chang, Amy T Y},
  title = {The Role of Metacognition, Intolerance of Uncertainty, and Cognitive‐Attentional Syndrome in Differentiating Fear of Cancer Recurrence},
  journal = {Psycho-Oncology},
  year = {2026},
  volume = {35},
  number = {5},
  doi = {10.1002/pon.70475}
}
Kostenlos starten →